Nkarta, Inc. SEC filings NKTX
Nkarta, Inc. has 438 filings in SEC EDGAR's recent list, going back to Sep 6, 2019. Its latest annual report, Form ARS, was filed on Apr 23, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 5, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Results of operations
|
Nov 5, 2026 | Nov 5, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 10, 2026 | Aug 10, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Jun 11, 2026 | Jun 10, 2026 |
| 8-K |
Current report
Results of operations
|
May 12, 2026 | May 12, 2026 |
| 8-K |
Current report
Other events
|
Mar 26, 2026 | Mar 25, 2026 |
| 8-K |
Current report
Results of operations
|
Mar 25, 2026 | Mar 25, 2026 |
| 8-K |
Current report
Results of operations
|
Nov 10, 2025 | Nov 10, 2025 |
| 8-K |
Current report
Results of operations
|
Aug 12, 2025 | Aug 12, 2025 |
| 8-K |
Current report
Officer or director change, Shareholder vote results, Regulation FD disclosure
|
Jun 6, 2025 | Jun 3, 2025 |
| 8-K |
Current report
Results of operations
|
May 14, 2025 | May 14, 2025 |
| 8-K |
Current report
Results of operations, Exit or restructuring costs, Officer or director change, Other events
|
Mar 26, 2025 | Mar 26, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 7, 2024 | Nov 7, 2024 |
| 8-K/A |
Amended current report
Results of operations
|
Aug 16, 2024 | Aug 13, 2024 |
| 8-K |
Current report
Material agreement
|
Aug 13, 2024 | Aug 13, 2024 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Jul 16, 2024 | Jul 10, 2024 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jun 27, 2024 | Jun 27, 2024 |
| 8-K |
Current report
Change to shareholder rights, Bylaw or fiscal year change, Shareholder vote results, Regulation FD disclosure
|
Jun 13, 2024 | Jun 13, 2024 |
| 8-K |
Current report
Results of operations
|
May 9, 2024 | May 9, 2024 |
| 8-K |
Current report
Other events
|
Mar 28, 2024 | Mar 25, 2024 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Mar 25, 2024 | Mar 25, 2024 |
| 8-K |
Current report
Results of operations
|
Mar 21, 2024 | Mar 21, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 8, 2024 | Jan 8, 2024 |
| 8-K |
Current report
Results of operations
|
Nov 9, 2023 | Nov 9, 2023 |
| 8-K |
Current report
Results of operations, Exit or restructuring costs, Regulation FD disclosure, Other events
|
Oct 17, 2023 | Oct 16, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 16, 2023 | Oct 16, 2023 |
| 8-K |
Current report
Results of operations
|
Aug 10, 2023 | Aug 10, 2023 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Jul 5, 2023 | Jun 29, 2023 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jun 27, 2023 | Jun 27, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 26, 2023 | Jun 26, 2023 |
| 8-K |
Current report
Bylaw or fiscal year change, Shareholder vote results
|
Jun 9, 2023 | Jun 9, 2023 |
| 8-K |
Current report
Results of operations
|
May 11, 2023 | May 11, 2023 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Mar 30, 2023 | Mar 28, 2023 |
| 8-K |
Current report
Results of operations
|
Mar 16, 2023 | Mar 16, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 9, 2023 | Jan 9, 2023 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Dec 5, 2022 | Dec 5, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
Dec 2, 2022 | Dec 2, 2022 |
| 8-K |
Current report
Results of operations
|
Nov 9, 2022 | Nov 9, 2022 |
| 8-K |
Current report
Results of operations
|
Aug 11, 2022 | Aug 11, 2022 |
| 8-K |
Current report
Shareholder vote results
|
Jun 10, 2022 | Jun 8, 2022 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
May 16, 2022 | May 13, 2022 |
| 8-K |
Current report
Results of operations
|
May 12, 2022 | May 12, 2022 |
| 8-K |
Current report
Other events
|
Apr 28, 2022 | Apr 28, 2022 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Apr 25, 2022 | Apr 25, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
Apr 22, 2022 | Apr 22, 2022 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Mar 29, 2022 | Mar 28, 2022 |
| 8-K |
Current report
Results of operations
|
Mar 17, 2022 | Mar 17, 2022 |
| 8-K |
Current report
Results of operations
|
Nov 10, 2021 | Nov 10, 2021 |
| 8-K |
Current report
Material agreement, New debt
|
Oct 22, 2021 | Oct 21, 2021 |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 7, 2021 | Oct 7, 2021 |
| 8-K |
Current report
Results of operations
|
Aug 12, 2021 | Aug 12, 2021 |
| 8-K |
Current report
Material agreement, New debt, Regulation FD disclosure
|
Jul 14, 2021 | Jul 9, 2021 |
| 8-K |
Current report
Shareholder vote results
|
Jun 15, 2021 | Jun 11, 2021 |
| 8-K |
Current report
Results of operations
|
May 13, 2021 | May 13, 2021 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
May 6, 2021 | May 5, 2021 |
| 8-K |
Current report
Regulation FD disclosure
|
Apr 28, 2021 | Apr 28, 2021 |
| 8-K |
Current report
Results of operations
|
Mar 25, 2021 | Mar 25, 2021 |
| 8-K |
Current report
Material agreement
|
Jan 19, 2021 | Jan 14, 2021 |
| 8-K |
Current report
Officer or director change
|
Jan 13, 2021 | Jan 8, 2021 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Nov 12, 2020 | Nov 12, 2020 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Oct 5, 2020 | Oct 2, 2020 |
| 8-K |
Current report
Results of operations
|
Aug 20, 2020 | Aug 20, 2020 |
| 8-K |
Current report
Bylaw or fiscal year change, Other events
|
Jul 14, 2020 | Jul 14, 2020 |
Showing 62 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- NKTX (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- South San Francisco, CA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1787400
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.